Edition:
United States

Profile: Allergan plc (AGN)

AGN on New York Consolidated

204.65USD
22 Sep 2017
Change (% chg)

$1.99 (+0.98%)
Prev Close
$202.66
Open
$202.50
Day's High
$209.25
Day's Low
$201.42
Volume
3,903,818
Avg. Vol
2,245,197
52-wk High
$256.80
52-wk Low
$184.50

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.

Company Address

Allergan plc

Clonshaugh Business And Technolo
Coolock
DUBLIN     D17 E400
P: +35321.65235000

Company Web Links